HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German Industry Urges Progress On Botanicals

Executive Summary

Germany's BPI is warning consumers to be wary of unapproved health claims made by botanical foods and supplements.

You may also be interested in...



European Commission Suggests ‘Traditional Use’ Could Resolve Botanicals Deadlock

Five years in the making, the European Commission delivers its assessment of the botanical ingredients in food supplements situation, suggesting that 'traditional use' may be a way out of the deadlock. 

Over The Counter, 20 Sept 2021: Being A Self-Care 'Source Of Truth' With TheScienceGrad's Natasha Barrow

HBW Insight speaks to regulatory expert and TheScienceGrad founder Natasha Barrow about trust in self-care, and how consumer healthcare companies can become a 'source of truth' in a confusing and misleading world.

GSK Smiles On Corsodyl And Sensodyne Oral Care Brands With Big Budget UK Campaigns

GSK Consumer Healthcare shows Corsodyl and Sensodyne some love with two big budget marketing campaigns in the UK. 

Topics

UsernamePublicRestriction

Register

RS148640

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel